Excessively high magnetic resonance signal in preterm infants and neuropsychobehavioural follow-up at 2 years

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 2, 2005, Pages 365-375

  Domizio, S ^a   Barbante, E ^a   Puglielli, C ^a   Clementini, E ^a   Domizio, R ^a   Sabatino, G M D ^b   Albanese, A ^b   Colosimo, C ^a   Sabatino, Guiseppe ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

CD38; Chronic lymphocytic leukemia; NAD + glycohydrolase; NAD+ metabolism

Indexed keywords

ACIDOSIS; ALKALOSIS; APGAR SCORE; APPARATUS; ARTICLE; ASSISTED VENTILATION; BRAIN INJURY; BRAIN MATURATION; CONTROLLED STUDY; DIFFUSE EXCESSIVE HIGH SIGNAL INTENSITY; DIFFUSION WEIGHTED IMAGING; DISABILITY; EVALUATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; IMAGE ANALYSIS; ITALY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PREMATURITY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SIGNAL DETECTION; WHITE MATTER INJURY;

EID: 20444505636     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800218     Document Type: Article

References (40)

1. Cooke R.W. 1999. Trends in incidence of cranial ultrasound lesions and cerebral palsy in very low birthweight infants 1982-93. Arch. Dis. Child Fetal Neonatal. 80:115.
2. Heuchan A.M., N. Evans, D.J. Henderson Smart and J.M. Simpson. 2002. Perinatal risk factors for major intraventricular haemorrhage in the Australian and New Zealand Neonatal Network, 1995-97. Arch. Dis. Fetal Neonatal. 86:86.
3. Maalouf E.F., P.J. Duggan and M.A. Rutherford. 1999. Magnetic resonance imaging of the brain in a cohort of extremely preterm infants. J. Pediatrics 135:351.
4. De Vries L., F. Groenendal and L.C. Meiners. 2002. Ischemic lesions in the preterm brain. In MRI of the Neonatal Brain. M. Rutherford, ed. Saunders. Philadelphia, p. 155.
5. Maalouf E.F., P.J. Duggan and S.J. Counsell. 2001. Comparison of finding on cranial ultrasound and magnetic resonance imaging in preterm infants. J. Pediatrics 107:719.
6. Miller S.P., D.B. Vigneron and R.G. Henry. 2002. Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J. Magn. Reson. Imaging 16:62.
7. Tanner S.F., L.A. Ramenghi and J.P. Ridgway. 2000. Quantitative comparison of intrabrain diffusion in adults and preterm and term neonates and infants. Am. J. Roentgenol. 174:1643.
8. Huppi P.S., B. Murphy and S.E. Maier. 2001. Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 107:455.
9. Counsell S.J., J.M. Allsop, M.C. Harrison, D.J. Larkman and M.A. Rutherford. 2003. Diffusion weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics 112:1.
10. Huppi P.S., S.E. Maier and S. Peled. 1998. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr. Res. 44:584.
11. Domizio S., G.M.D. Sabatino, A. Albanese, E. Barbante, C. Puglielli, M. Di Giannantonio, R. Quartesan, R. Domizio and G. Sabatino. 2004. Focal cerebral infarction in newborn:description of three cases. Eu. J. Inflamm. 2:141.
12. Arthur R. and L.A. Ramenghi. 2001. Imaging the neonatal brain. In Fetal and Neonatal Neurology and Neurosurgery. M.I. Levene, F.A. Chervenak, M. Whittle, ed. Churchill Livingstone London, p.57.
13. Evans D.J., A.M. Childs and L.A. Ramenghi. 1997. Magnetic-resonance imaging of the brain of premature infants. Lancet 350:522.
14. Gibson A.T. 1998. The outcome for infants born at extreme prematurity. Curr. Paediatr. 8:108.
15. Hack M. and A.A. Fanaroff. 1999. Outcomes of children of ELBW and gestational age in the nineties. Early Hum. Dev. 53:193.
16. Thorp J.A. and R. Scott Rushing. 1999. Umbilical cord blood analysis. Obstet. Gynecol. Clin. North Am. 26:45.
17. Arikan G.M., H.S. Scholz and E. Petrus. 2000. Cord blood oxygen saturation in vigorous infants at birth: what is normal? Br. J. Obstet. Gynaecol. 107:987.
18. Goodwin T.M. 1999. Clinical implications of perinatal depression. Obst. Gynecol. Clin. North Am. 26:74.
19. Gilstrap L.C., K.J. Leveno, J. Burris, M. Williams and B.B. Little. 1989. Diagnosis of birth asphyxia on the basis of fetal pH, Apgar score and newborn cerebral dysfunction. Am. J. Obst. Gynecol. 161:825.
20. ACOG Committee on Obstetric Pratice, American Academy of Pediatrics Committee on Fetus and Newborn. 1996. Use and abuse of the Apgar Score. Pediatrics 98:14.
21. Roberton N.R.C. 1999. Resuscitation of the newborn. In Textbook of Neonatology. J. M. Rennie and N.R.C. Roberton, ed. Saunders Philadelphia, p.352.
22. Casey B.M., D.D. McIntire and K.J. Leveno. 2001. The continuing value of the Apgar score for the assessment of the newborn infants. N. Engl. J. Med. 344:467.
23. American Heart Association, American Academy of Pediatrics, 2002. Neonatal resuscitation program. In Neonatal Resuscitation. Instructor's Manual, ed. Zaichkin New York, p. 19.
24. Rijken M., G.M.S.J. Stoelhorst and S.E. Martens. 2003. Mortality and neurologic, mental and psychomotor development at 2 years in infants born less than 27 weeks' gestation: the Laiden Follow-up Project on Prematurity. Pediatrics 112:351.
25. Drillien C.M. 1972. Abnormal neurological signs in the first year of life. Possible prognostic significance. Develop. Med. Child. Neurol. 14:575.
26. Holtrop P.C., L.M. Ertzbischoff, C.L. Roberts, D.G. Batton and R.P. Lorenz. 1994. Survival and short-term outcome in newborns of 23 to 25 weeks' gestation. Am. J. Obst. Gynecol. 170:1266.
27. Cooke R.W.L. 1996. Improved outcome for infants at limits of viability. Eur. J. Pediatr. 155:655.
28. Balatsinou L., G. Di Gioacchino, G. Sabatino, E. Cavallucci, R. Caruso, E. Gabriele, S. Ramondo, L. Di Giampaolo, N. Verna and M. Di Gioacchino. 2004. Asthma worsened by benzoate contained in some antiasthmatic drugs. Int. J. Immunopathol. Pharmacol. 17:225.
29. Demidova T.N. and M.R. Hamblin. 2004. Targeted photodynamic therapy to inflammatory cells and pathogens. Int. J. Immunopathol. Pharmacol. 17:117.
30. Sodin-Semrl S., A. Spagnolo, R. Mikus, B. Barbaro, J. Varga and S. Fiore. 2004. Lipoxin A4 and serum amyloid A elicit opposite interleukin-8 and NF-kB responses via the common ALX receptor. Int. J. Immunopathol. Pharmacol. 17:145.
31. Gritti D., A. Malinverno, C. Gasparetto, C.J. Wiedermann and G. Ricevuti. 2004. Attenuation of leukocyte [beta]2-integrin expression by antithrombin-III. Int. J. Immunopathol. Pharmacol. 17:27.
32. Kempuraj D., B. Madhappan, R. Sheeladlevi, M. Nazer, S. Christodoulou, J. Reginald, N. Suthinthirarajan and A. Namasivayam. 2004. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors. Int. J. Immunopathol. Pharmacol. 17:57.
33. Vojdani A., J. B. Pangborn, E. Vojdani and E.L. Cooper. 2003. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16:189.
34. Ramakrishnan R., M.Y. Nazer, N. Suthanthirarajan and A. Namasivayam. 2003. An experimental analysis of the catecholamines in hyperglycemia and acidosis induced rat brain. Int. J. Immunopathol. Pharmacol. 16:233.
35. Roux M.E., M.G. Marquez, S. Olmos, C.A. Frecha and A. Florin-Christensen. 2003. Compartmentalisation between Gut and Lung mucosae in a model of secondary immunodeficiency. Effect of thymomodulin. Int. J. Immunopathol. Pharmacol. 16:151.
36. Cross M.L. 2004. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites. Int. J. Immunopathol. Pharmacol. 17:127
37. Sardella G., D. Accapezzato, A. Di Roma, C. Iacoboni, V. Francavilla, G. Benedetti, C. Musto, F. Fedele, G. Bruno and M. Paroli. 2004. Integrin b2-chain (CD18) over-expression on CD4+ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int. J. Immunopathol. Pharmacol. 17:165.
38. Romano S., S. Fratini, M. Di Pietro, G. Schiavoni, M. Nicoletti, F. Chiarotti, M. del Piano, M. Penco and R. Sessa. 2004. Chlamydia Pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up. Int. J. Immunopathol. Pharmacol. 17:209.
39. Ghezzi P. and D. Ungheri. 2004. Synergistic combination of n-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model. Int. J. Immunopathol. Pharmacol. 17:99.
40. Kempuraj D., S. Frydas, P. Conti, K. Kandere, W. Boucher, R. Letourneau, B. Madhappan, S.H. Huang, S. Koreaki, S. Christodoulou and T.C. Theoharides. 2003. Interleukin-25: a new IL-17 family member with growth factor/inflammatory action. Int. J. Immunopathol. Pharmacol. 16:185